calendar
285 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion
next 91 dayslessmore
MonWedFri
285 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
No description on file. Bork keeps sniffing.
Prescription Drug User Fee Act goal date of July 17, 2026
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL